STOCK TITAN

Kestra Medical (NASDAQ: KMTS) executive sells 3,580 shares for tax withholding

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

KESTRA MEDICAL TECHNOLOGIES, LTD. executive Traci S. Umberger, General Counsel and Chief Administrative Officer, reported a non-discretionary sale of 3,580 common shares on August 4, 2026, to cover tax withholding obligations arising from the vesting and settlement of restricted stock units. The sale was executed at a weighted average price of $24.0428 per share, with individual prices ranging from $23.8000 to $24.4200.

Following this tax-related sale, Umberger directly holds 195,825 common shares of Kestra Medical Technologies, Ltd.

Positive

  • None.

Negative

  • None.
Insider Umberger Traci S
Role See Remarks
Sold 3,580 shs ($86K)
Type Security Shares Price Value
Sale Common Shares F1, F2 3,580 $24.0428 $86K
Holdings After Transaction: Common Shares — 195,825 shares (Direct)
Footnotes (2)
  1. F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
  2. F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.8000 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Shares Sold 3,580 common shares Non-discretionary sell-to-cover transaction on August 4, 2026
Weighted Average Sale Price $24.0428 per share Average price for 3,580 shares sold on August 4, 2026
Sale Price Range $23.8000 to $24.4200 Range of individual trade prices within the reported sale
Shares Held After Transaction 195,825 common shares Direct holdings of Traci S. Umberger following the sell-to-cover sale
restricted stock units financial
"vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"pursuant to sell to cover transactions to satisfy tax withholding"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
tax withholding obligations financial
"transactions to satisfy tax withholding obligations in connection with the vesting"
weighted average price financial
"The price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did KMTS report for Traci S. Umberger?

KMTS reported that Traci S. Umberger sold 3,580 common shares on August 4, 2026. The sale was a non-discretionary, sell-to-cover transaction to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units.

At what price were the 3,580 KMTS shares sold by the executive?

The 3,580 KMTS shares were sold at a weighted average price of $24.0428 per share. According to the filing, actual sale prices ranged between $23.8000 and $24.4200, and detailed breakdowns are available from the reporting person upon request.

How many KMTS shares does Traci S. Umberger hold after this transaction?

After the August 4, 2026 transaction, Traci S. Umberger directly holds 195,825 KMTS common shares. This figure reflects her position following the sale of 3,580 shares executed to cover tax withholding obligations associated with restricted stock unit vesting.

Was the KMTS insider sale a discretionary trade or for tax withholding?

The KMTS trade was non-discretionary and executed to cover tax withholding obligations. A footnote explains the shares were sold pursuant to sell-to-cover arrangements linked to the vesting and settlement of restricted stock units, rather than an open-market discretionary decision.

Did the KMTS Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox was not selected, and a footnote characterizes the transaction as a nondiscretionary sale to cover tax withholding from RSU vesting, rather than a sale executed under a pre-arranged Rule 10b5-1 trading plan.

What role does the insider in this KMTS Form 4 filing hold?

The reporting person, Traci S. Umberger, serves as General Counsel and Chief Administrative Officer and is also listed as a director of Kestra Medical Technologies, Ltd., according to the information provided in the Form 4.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Umberger Traci S

(Last)(First)(Middle)
3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)
KIRKLAND WASHINGTON 98033

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/04/2026S(1)3,580D$24.0428(2)195,825D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.8000 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Remarks:
General Counsel and Chief Adminstrative Officer
/s/ Traci S. Umberger08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)